Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome. Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health.

Bonumose is developing a proprietary, cost-effective enzymatic process to bring these natural, low-glycemic sugars to market. The company takes starches left over from, for example, potato processing and, leveraging the natural power of enzymes, develops them into naturally-occurring ingredients in industrial-scale quantities. The webinar will also include a discussion of Bonumose’s patented process, one which permits the mass market application of tagatose and other nutritious sugars.

Learn more at: http://bonumose.com/